Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations

The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. The use of this class of medications is currently limited to venous thromboembolic therapy and prophylaxis, in addition to s...

Full description

Saved in:
Bibliographic Details
Main Authors: Sherif Elhosseiny, Hassan Al Moussawi, Jean M. Chalhoub, James Lafferty, Liliane Deeb
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2019/4383269
Tags: Add Tag
No Tags, Be the first to tag this record!